Large-scale proteomic characterization of melanoma expressed proteins reveals nestin and vimentin as biomarkers that can potentially distinguish melanoma subtypes

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 5031-5040

  Qendro, Veneta ^a   Lundgren, Deborah H ^a   Rezaul, Karim ^a   Mahony, Forrest ^a   Ferrell, Nicholas ^a   Bi, Andrew ^a   Latifi, Ardian ^a   Chowdhury, Daniyal ^a   Gygi, Steven ^b   Haas, Wilhelm ^b   Wilson, Lori ^c   Murphy, Michael ^a   Han, David K ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOWARD UNIVERSITY HOSPITAL   (United States)

Author keywords

biomarkers; melanoma; nestin; proteomics; quantitative proteomics; spectral counting; vimentin

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; FIBRONECTIN; HISTONE H2A1B; LIPOCORTIN 1; NESTIN; NUCLEAR PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; VIMENTIN; NES PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOMA; MELANOMA CELL LINE; METASTATIC MELANOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY; SKIN TUMOR; TISSUE MICROARRAY;

HUMANS; MELANOCYTES; MELANOMA; NESTIN; PROTEOMICS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS; TANDEM MASS SPECTROMETRY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84908876168     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr5006789     Document Type: Article

References (31)

1. Wurn, E.; Soyer, H. Scanning for melanoma Aust. Prescriber 2010, 33, 150-155
2. Garbe, C.; Eigentler, T. K. Diagnosis and treatment of cutaneous melanoma: state of the art 2006 Melanoma Res. 2007, 17, 117-127
3. Homsi, J.; Kashani-Sabet, M.; Messina, J.; Daud, A. Cutaneous melanoma: prognostic factors Cancer Control 2005, 12, 223-229
4. Vitzthum, F.; Behrens, F.; Anderson, N. L.; Shaw, J. H. Proteomics: from basic research to diagnostic application. a review of requirements & needs J. Proteome Res. 2005, 4, 1086-1097
5. Sabel, M. S.; Liu, Y.; Lubman, D. M. Proteomics in melanoma biomarker discovery: great potential, many obstacles Int. J. Proteomics. 2011, 2011, 181890
6. Herlyn, M. Human melanoma: development and progression Cancer Metastasis Rev. 1990, 9, 101-112
7. Shevchenko, A.; Wilm, M.; Vorm, O.; Jensen, O. N.; Podtelejnikov, A. V.; Neubauer, G.; Shevchenko, A.; Mortensen, P.; Mann, M. A strategy for identifying gel-separated proteins in sequence databases by MS alone Biochem. Soc. Trans. 1996, 24, 893-896
8. Hwang, S.; Thumar, J.; Lundgren, D. H.; Rezaul, K.; Mayya, V.; Wu, L.; Eng, J.; Wright, M. E.; Han, D. Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues Oncogene 2007, 26, 65-76
9. Rezaul, K.; Murphy, M.; Lundgren, D.; Wilson, L.; Han, D. Combined mass spectrometry-and immunohistochemistry-based approach to determine protein expression in archival melanoma-proof of principle Pigm. Cell Melanoma Res. 2010, 23, 849-852
10. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for mass spectrometry-based proteomics Methods Mol. Biol. 2010, 604, 55-71
11. Liu, H.; Sadygov, R. G.; Yates, J. R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics Anal. Chem. 2004, 76, 4193-4201
12. Pavelka, N.; Pelizzola, M.; Vizzardelli, C.; Capozzoli, M.; Splendiani, A.; Granucci, F.; Ricciardi-Castagnoli, P. A power law global error model for the identification of differentially expressed genes in microarray data BMC Bioinf. 2004, 17 (5) 203
13. Pavelka, N.; Fournier, M. L.; Swanson, S. K.; Pelizzola, M.; Ricciardi-Castagnoli, P.; Florens, L.; Washburn, M. P. Statistical similarities between transcriptomics and quantitative shotgun proteomics data Mol. Cell. Proteomics. 2008, 7, 631-44
14. Lundgren, D. H.; Hwang, S. I.; Wu, L.; Han, D. K. Role of spectral counting in quantitative proteomics Expert Rev. Proteomics. 2010, 7, 39-53
15. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing J. R. Stat. Soc., Ser. B 1995, 57 (1) 289-300
16. Walia, R.; Jain, D.; Mathur, S. R.; Iyer, V. K. Spindle cell melanoma: A comparison of the cytomorphological features with the epithelioid variant Acta Cytol. 2013, 57, 557-561
17. Sabah, M.; Leader, M. Animal-type melanoma: a rare type of malignant melanoma with an indolent clinical behaviour Clin. Med. Oncol. 2007, 1, 95-98
18. Gaggioli, C.; Sahai, E. Melanoma invasion-current knowledge and future directions Pigm. Cell Res. 2007, 20, 161-172
19. Chernoivanenko, I.; Minin, A. A. Role of vimentin in cell migration Ontogenez. 2013, 44, 186-202
20. Paccione, R.; Miyazaki, H.; Patel, V.; Waseem, A.; Gutkind, J.; Zehner, Z.; Yeudall, W. Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility Mol. Cancer Ther. 2008, 7, 2894-2903
21. Wei, J.; Xu, G.; Wu, M.; Zhang, Y.; Li, Q.; Liu, P.; Zhu, T.; Song, A.; Zhao, L.; Han, Z.; Chen, G.; Wang, S.; Meng, L.; Zhou, J.; Lu, Y.; Ma, D. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via scr regulation Anticancer Res. 2008, 28, 327-334
22. Klein, W.; Wu, B.; Zhao, S.; Wu, H.; Klein-Szanto, A.; Tahan, S. Increased expression of stem cell markers in malignant melanoma Mod. Pathol. 2007, 20, 102-107
23. Doetsch, F.; Garcia-Verdugo, J. M.; Alvarez-Buylla, A. Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain J. Neurosci. 1997, 17, 5046-5061
24. Johansson, C. B.; Momma, S.; Clarke, D. L.; Risling, M.; Lendayl, U.; Frisen, J. Identification of a neural stem cell in the adult mammalian central nervous system Cell 1999, 96, 25-34
25. Piras, F.; Perra, M. T.; Murtas, D.; Minerba, L.; Floris, C.; Maxia, C.; Demurtas, P.; Ugalde, J.; Ribatti, D.; Sirigu, P. The stem cell marker nestin predicts poor prognosis in human melanoma Oncol. Rep. 2010, 23, 17-24
26. Li, M.; Zhang, B.; Sun, B.; Wang, X.; Ban, X.; Sun, T.; Liu, Z.; Zhao, X. A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis J. Exp. Clin. Cancer Res. 2010, 29, 109
27. Koenig, A.; Wojcieszyn, J.; Weeks, B. R.; Modiano, J. F. Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cell lines and twenty-nine retrospective cases of canine melanoma Vet. Pathol. 2001, 38, 427-435
28. Byun, Y.; Chen, F.; Chang, R.; Trivedi, M.; Green, K. J.; Cryns, V. L. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis Cell Death Differ. 2001, 8, 443-450
29. Bargagna-Mohan, P.; Hamza, A.; Kim, Y. E.; Ho, Y. K.; Mor-Vaknin, N.; Wendschlag, N.; Liu, J.; Evans, R. M.; Markovitz, D. M.; Zhan, C. G.; Kim, K. B.; Mohan, R. The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin Chem. Biol. 2007, 14, 623-634
30. Dinsdale, D.; Lee, J. C.; Dewson, G.; Cohen, G. M.; Peter, M. E. Intermediate filaments control the intracellular distribution of caspases during apoptosis Am. J. Pathol. 2004, 164, 395-407
31. Cheung, K. J.; Gabrielson, E.; Werb, Z.; Ewald, A. J. Collective invasion in breast cancer requires a conserved basal epithelial program Cell 2013, 155, 1639-1651